Episode Summary
Executive Summary: Arif Karim of Ensemble Capital Management discusses his firm's approach to investing through COVID-19, including how they adjusted their portfolio by analyzing balance sheets and revenue resilience. He then provides an in-depth intrinsic value pitch for Intuitive Surgical, a leader in robotic-assisted surgery. The episode concludes with hosts Preston and Stig addressing a listener's question about the disconnect between the surging stock market and the struggling economy, attributing it to unprecedented Fed intervention and dollar liquidity.
Main Topics: Investing Through the COVID-19 Pandemic (Priority: 5/5): Arif details how Ensemble prepared for the pandemic by monitoring early signals from China and Italy. They stress-tested portfolio holdings like Booking.com (surviving a 70% revenue decline) and focused on companies with strong balance sheets and access to capital. They pruned lower-conviction positions and added to higher-conviction ones. Intrinsic Value Pitch: Intuitive Surgical (ISRG) (Priority: 5/5): Arif presents Intuitive Surgical as a competitively advantaged company with a two-decade lead in robotic surgery, a 'razor-blade' business model with high margins on both robots and consumables, and a large addressable market growing as new procedures and geographic expansion unfold. He values the stock at around $700 using a DCF analysis, citing 80%+ returns on invested capital. The Role of Secular Trends and Competitive Advantage (Priority: 4/5): Arif argues that investors don't need to find undiscovered secular trends to outperform. Instead, they should focus on companies with durable competitive advantages that can capitalize on well-known trends (e.g., e-commerce, digital payments). He uses Amazon, MasterCard, and Netflix as examples. Macro Context: Abundant Capital and Zero Interest Rates (Priority: 4/5): Arif discusses how the global shift to abundant, near-zero-cost capital changes the investment landscape. He suggests the cost of capital is now effectively zero, making it crucial to find companies that can generate high returns on invested capital with long growth runways. Market Disconnect: Stock Market vs. Economy (Priority: 5/5): Hosts Preston and Stig address a listener's confusion about the stock market rallying despite high unemployment. They explain that the stock market is forward-looking, different from the economy, and is being heavily manipulated by the Fed's massive liquidity injections (balance sheet from $4T to $7T). This drives asset prices higher as investors seek sound money alternatives to depreciating cash. Competitive Dynamics in Surgical Robotics (Priority: 3/5): Arif describes Intuitive's moat: a 20-year head start, safety record, 50,000 trained surgeons, and a next-gen Da Vinci XI platform. Competitors like Medtronic and Johnson & Johnson are delayed, with Intuitive likely releasing a 5th-gen system by the time they launch their 1st-gen, widening the gap. COVID-19 Impact on Intuitive Surgical (Priority: 4/5): Short-term negative: procedures down 65% in the US and 60% globally at the time of the call. Long-term positive: a backlog of deferred procedures (many for cancer) will need to be performed, and Intuitive's focus on R&D means they may emerge even stronger relative to distracted competitors.
Key Arguments: Investors should not rely solely on discovering new secular trends; they can profit from well-known trends if they invest in competitively advantaged businesses. Intuitive Surgical's competitive moat is based on a two-decade head start, high switching costs, and a razor-blade business model that produces high margins on both systems and consumables. The stock market's rally during economic hardship is primarily driven by massive Fed liquidity, not the health of the underlying economy. Investors are fleeing cash and buying assets with a fixed supply. In a world of abundant capital with near-zero cost, the key to long-term investing is finding companies that can earn high returns on invested capital and reinvest for decades (global scale). Intuitive Surgical's intrinsic value is estimated at $700, based on a bottoms-up DCF that accounts for procedural growth, market penetration, and competitive dynamics. The pandemic has created a backlog of elective surgeries that will eventually be performed, providing a tailwind for Intuitive Surgical's procedure volume over the next 3-5 years.
Data Points: Market drawdown and recovery: Largest 50-day trading rally ever; close to all-time highs - Arif describes the volatility since February 2020. Booking.com revenue stress test: 70% revenue decline to start losing money - Arif explains how they tested portfolio resilience. Intuitive Surgical gross margins: 60-65% on robots; 80-90% on instruments - Arif describes the razor-blade business model. Intuitive Surgical procedures in 2019: 1.2 million globally - Arif gives the current scale of the business. Da Vinci robot cost and procedure cost: $1-2 million per robot; $1,800-1,900 per procedure in instrument revenue - Arif breaks down the economics. Intuitive Surgical robots in the field: 5,600-5,800 robots globally - Arif mentions the installed base. Procedure decline in China (Feb 2020): 90% reduction; recovered to 80% of pre-COVID level by April - Arif gives short-term COVID impact data. US procedure decline during COVID: 65% at time of Q1 call - Arif gives US-specific impact. Intrinsic value estimate for ISRG: $700 - Arif provides his valuation target. Fed balance sheet expansion: $4 trillion to $7 trillion in three months - Preston describes monetary intervention. Intuitive ROIC: 80%+ - Arif notes the high returns on invested capital.
Pivotal Quotes: "I don't think you necessarily need to bet on undiscovered secular trends. I think the most important part of investment analysis is being a business analyst and understanding that those companies that are competitively advantaged in the way that they're trying to capitalize on secular trends... can create outsized returns." — Arif Karim: Explaining his investment philosophy regarding secular trends. "It's not necessary to bet on things that other people haven't seen. And I'll give you an example: e-commerce has been around for 20, 30 years, but Amazon has still way outperformed market returns." — Arif Karim: Challenging the idea that known trends are fully priced in, using Amazon as an example. "The stock market is not the economy. It rhymes, but it's not the same thing... The stock market is forward-looking, while the economy is backward-looking... and we have the Fed manipulating the market big time." — Stig Brodersen: Explaining why the stock market can rise during high unemployment. "My argument is today you're not seeing [sound money] because all these interest rates are pegged to nothing percent. And if they're pegged to nothing percent, you don't have a cost of capital and you can't do economic calculation for the valuation of things." — Preston Pysh: Arguing that traditional valuation methods struggle in a zero-interest-rate environment dominated by Fed intervention.
Implications: Investors should not rely solely on traditional valuation in a zero-interest-rate, highly-manipulated environment. A blended approach incorporating momentum and macro liquidity factors may be necessary. Companies with durable moats, high ROIC, and global scale (like Intuitive Surgical) are best positioned to outperform, even if their near-term earnings are hit by the pandemic.
About We Study Billionaires
We interview and study famous financial billionaires, including Warren Buffett, Ray Dalio, and Howard Marks, and teach you what we learn and how you can apply their investment strategies in the stock market. We Study Billionaires is the largest stock investing podcast show in the world with 180,000,000+ downloads and is hosted by Stig Brodersen, Preston Pysh, William Green, Clay Finck, and Kyle Grieve. This podcast also includes the Richer Wiser Happier series hosted by best-selling author Wi...